Company & Sponsor Intelligence

Qilu Hospital of Shandong University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials4
Recruiting1
Completed3
Countries1

Therapeutic footprint

adhdparkinsons

Indexed studies

NCT07591896Adding VR-Based Episodic Future Thinking Training to Executive- Function Training for Children With ADHD: A Randomized Controlled Trial
adhd · China
NA
NCT06090929STN-DBS and the Risk of Sialorrhea
parkinsons · China
NA
NCT07154732Transcranial Photobiomodulation With Multiple Interventions in Children With Attention-Deficit/Hyperactivity Disorder
adhd ·
NA
NCT05901350The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain Stimulation
parkinsons · China
NA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →